 Connection
John Hamner to Sentinel Lymph Node Biopsy
This is a "connection" page, showing publications John Hamner has written about Sentinel Lymph Node Biopsy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.471 |
|
|
|
-
Guenther JM, Ward A, Martin BJ, Cripe M, Beard T, Wisco O, Sharma R, Leong SP, Essner R, Clark JI, Hamner J, Sickle-Santanello B, Yamamoto M. A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEP. Cancer Med. 2025 Apr; 14(7):e70839.
Score: 0.222
-
Guenther JM, Ward A, Martin BJ, Cripe M, Sharma R, Leong SP, Clark JI, Hamner J, Beard T. A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma. World J Surg Oncol. 2025 Jan 03; 23(1):5.
Score: 0.218
-
Al-Qurayshi Z, Hassan M, Srivastav S, Sperry S, Pagedar N, Hamner J, Kandil E. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective. Oncology. 2017; 93(1):18-28.
Score: 0.032
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|